Applied DNA Sciences shares are trading higher after the company announced it launched the Mpox Clade I and Clade II testing service.
Portfolio Pulse from Benzinga Newsdesk
Applied DNA Sciences shares rose following the launch of their Mpox Clade I and Clade II testing service.
September 11, 2024 | 1:59 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Applied DNA Sciences shares increased after the company introduced a new testing service for Mpox Clade I and Clade II.
The launch of a new testing service is a positive development for Applied DNA Sciences, likely driving investor interest and boosting the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100